EUROPHARMPROJECT OÜ - 11256642 | Print Summary Report
STORYBOOK OÜ Tähe 129b, Tartu, 50113 ESTONIA (+372)7446645 info@scorestorybook.ee ssb.ee
[mo_oauth_login]

EUROPHARMPROJECT OÜ

Summary report

Date of report 24.03.2025

EUROPHARMPROJECT OÜ
11256642 - Registered
Founded in 23.05.2006
Fixed capital 2,556 €

VAT  
EE101106227 (start 20.12.2006)
start end
20.12.2006 -

Add EUROPHARMPROJECT OÜ data to your system

download JSON download CSV

Add EUROPHARMPROJECT OÜ data to your information system with one click or download a CSV file. The data is enriched with direct links to Storybook reports. See also the list of machine-readable data.

Don't have CRM? Read more

keywords

  • arvutialased konsultatsioonid

EUROPHARMPROJECT OÜ

Scores and ratings

Reputation score

What is Reputation score?

Credit Score

Trustworthy 0.01

Loader

What is Credit Score?

Open the reports you want to print

Employees and salaries

EUROPHARMPROJECT OÜ

Number of employees and estimated average salaries
?

EUROPHARMPROJECT OÜ

Employee taxes and performance analysis
?
QuarterLabor taxes
paid		Number of employees
Turnover
Per Employee		Profit
per employee
2024 IV........................
2024 III........................
2024 II........................
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................
2017 I........................
2016 IV........................
2016 III........................
2016 II........................
2016 I........................
2015 IV........................
2015 III........................
2015 II........................
2015 I........................

Deciders and beneficiaries

EUROPHARMPROJECT OÜ

Decision-makers
?

Sergei Netšajev

Relations: 2
Turnover 2024: 607 €
Employees:
Sergei Netšajev
★★★★

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 810

Date of birth: ......

Active relations 2

Computer ConsultationsActivities of housing associations
*Every member of the management board may represent the private limited company in concluding all transactions.

EUROPHARMPROJECT OÜ

History of right of representation
?
Field
Information and Communication
Business age
18y
Beneficial country:
Estonia
 
Sergei Netšajev ... - ...
2006
2009
2011
2014
2017
2020
2022
2025
2006
2008
2009
2011
2013
2015
2016
2018
2020
2022
2023
2025

EUROPHARMPROJECT OÜ

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
0.01
..................
100%

Former owners

NameCredit ScorePaymentBeginningEnding
0.01
..................
0.01
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

EUROPHARMPROJECT OÜ

Goodwill

EUROPHARMPROJECT OÜ

Taxes paid and estimated average salaries

EUROPHARMPROJECT OÜ

Quarterly indicators
QuarterTurnoverTaxed turnoverLabour productivityLabour productivityEmployeesNational taxesLabor taxes
2024 IV* ............* ..............................
2024 III* ............* ..............................
2024 II* ............* ..............................
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................
2021 III* ............* ..............................
2021 II* ............* ..............................
2021 I* ............* ..............................
2020 IV* ............* ..............................
2020 III* ............* ..............................
2020 II* ............* ..............................
2020 I* ............* ..............................
2019 IV* ............* ..............................
2019 III* ............* ..............................
2019 II* ............* ..............................
2019 I* ............* ..............................
2018 IV* ............* ..............................
2018 III* ............* ..............................
2018 II* ............* ..............................
2018 I* ............* ..............................
2017 IV* ............* ..............................
2017 III* ............* ..............................
2017 II* ............* ..............................
2017 I* ............* ..............................
2016 IV* ............* ..............................
2016 III* ............* ..............................
2016 II* ............* ..............................
2016 I* ............* ..............................
2015 IV* ............* ..............................
2015 III* ............* ..............................
2015 II* ............* ..............................
2015 I* ............* ..............................

EUROPHARMPROJECT OÜ

Sales revenue by business area

EUROPHARMPROJECT OÜ

Sales revenue by country

EUROPHARMPROJECT OÜ

Financial indicators and prognosis

EUROPHARMPROJECT OÜ

Financial raiting: "GOOD" (2024 prognosis)
2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

EUROPHARMPROJECT OÜ

Annual reports
Year Period Submitted Report PDF
2023 01.01.2023–31.12.2023 28.06.2024 ......
2022 01.01.2022–31.12.2022 27.06.2023 ......
2021 01.01.2021–31.12.2021 22.06.2022 ......
2020 01.01.2020–31.12.2020 31.05.2021 ......
2019 01.01.2019–31.12.2019 11.10.2020 ......
2018 01.01.2018–31.12.2018 14.11.2019 ......
2017 01.01.2017–31.12.2017 06.07.2018 ......
2016 01.01.2016–31.12.2016 05.08.2017 ......
2015 01.01.2015–31.12.2015 31.07.2016 ......
2014 01.01.2014–31.12.2014 27.09.2015 ......
2013 01.01.2013–31.12.2013 30.09.2014 ......
2012 01.01.2012–31.12.2012 24.07.2013 ......
2011 01.01.2011–31.12.2011 26.02.2013 ......
2010 01.01.2010–31.12.2010 19.03.2012 ......
2009 01.01.2009–31.12.2009 09.08.2010 ......
2008 01.01.2008–31.12.2008 16.07.2009 ......
2007 01.01.2007–31.12.2007 04.12.2008 ......
2006 01.01.2006–31.12.2006 18.10.2007 ......

Liabilities and debts

EUROPHARMPROJECT OÜ

Credit score history and prognosis
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

EUROPHARMPROJECT OÜ

Reports and assets-liabilities overview 24.03.2025
?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

EUROPHARMPROJECT OÜ

Claims history
?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Private debt ...... €

Total debt claims: ...... €

Latest events
...... ......

EUROPHARMPROJECT OÜ

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2024 IV* ...... €...... €...... €...... €......
2024 III* ...... €...... €...... €...... €......
2024 II* ...... €...... €...... €...... €......
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......
2021 III* ...... €...... €...... €...... €......
2021 II* ...... €...... €...... €...... €......
2021 I* ...... €...... €...... €...... €......
2020 IV* ...... €...... €...... €...... €......
2020 III* ...... €...... €...... €...... €......
2020 II* ...... €...... €...... €...... €......
2020 I* ...... €...... €...... €...... €......
2019 IV* ...... €...... €...... €...... €......
2019 III* ...... €...... €...... €...... €......
2019 II* ...... €...... €...... €...... €......
2019 I* ...... €...... €...... €...... €......
2018 IV* ...... €...... €...... €...... €......
2018 III* ...... €...... €...... €...... €......
2018 II* ...... €...... €...... €...... €......
2018 I* ...... €...... €...... €...... €......
2017 IV* ...... €...... €...... €...... €......
2017 III* ...... €...... €...... €...... €......
2017 II* ...... €...... €...... €...... €......
2017 I* ...... €...... €...... €...... €......
2016 IV* ...... €...... €...... €...... €......
2016 III* ...... €...... €...... €...... €......
2016 II* ...... €...... €...... €...... €......
2016 I* ...... €...... €...... €...... €......
2015 IV* ...... €...... €...... €...... €......
2015 III* ...... €...... €...... €...... €......
2015 II* ...... €...... €...... €...... €......
2015 I* ...... €...... €...... €...... €......

EUROPHARMPROJECT OÜ

Bailiff's enforcement proceedings as of 24.03.2025
?

Bailiff's enforcement proceedings MISSING

EUROPHARMPROJECT OÜ

Regulations of the Payment Order Department as of 24.03.2025
?

Regulations of the Payment Order Department MISSING

EUROPHARMPROJECT OÜ

Court orders in the register as of 24.03.2025
?

Court order MISSING

EUROPHARMPROJECT OÜ

Decisions of the Consumer Disputes Committee as of 24.03.2025
?

Consumer disputes MISSING

EUROPHARMPROJECT OÜ

Court hearings as of 24.03.2025
?

Court hearings MISSING

EUROPHARMPROJECT OÜ

Rulings as of 24.03.2025
?

Court settlemets MISSING

EUROPHARMPROJECT OÜ

Notices and announcements as of 24.03.2025
?

Announcements MISSING

Marketing

Business network

EUROPHARMPROJECT OÜ

 Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

EUROPHARMPROJECT OÜ

 Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events found.

Failed to load monitoring events.

We value your privacy

We use cookies to improve your browsing experience, provide personalized ads or content, and analyze our traffic. By clicking "allow all", you agree to our use of all cookies.